{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:28:19Z","timestamp":1793413699487,"version":"4.5.0"},"reference-count":222,"publisher":"Elsevier","isbn-type":[{"value":"9780443295423","type":"print"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/bs.ampbs.2024.04.006","type":"book-chapter","created":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T19:24:12Z","timestamp":1717269852000},"page":"201-258","source":"Crossref","is-referenced-by-count":21,"title":["Staphylococcus aureus response and adaptation to vancomycin"],"prefix":"10.1016","author":[{"given":"Ana\u00eblle","family":"Fait","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie Fulaz","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack \u00c5ke Harry","family":"Abrahamsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Ingmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/bs.ampbs.2024.04.006_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10096-008-0602-7","article-title":"Intestinal carriage of Staphylococcus aureus: How does its frequency compare with that of nasal carriage and what is its clinical impact?","volume":"28","author":"Acton","year":"2009","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology"},{"issue":"2","key":"10.1016\/bs.ampbs.2024.04.006_bib2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1358\/dot.2005.41.2.882660","article-title":"Daptomycin: A new drug class for the treatment of Gram-positive infections","volume":"41","author":"Alder","year":"2005","journal-title":"Drugs of Today (Barcelona, Spain: 1998)"},{"issue":"10","key":"10.1016\/bs.ampbs.2024.04.006_bib3","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1128\/AAC.42.10.2590","article-title":"Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus","volume":"42","author":"Aubry-Damon","year":"1998","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"9","key":"10.1016\/bs.ampbs.2024.04.006_bib4","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1086\/606027","article-title":"Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: Prevalence, genotype, and clinical significance","volume":"200","author":"Bae","year":"2009","journal-title":"The Journal of Infectious Diseases"},{"issue":"9","key":"10.1016\/bs.ampbs.2024.04.006_bib705","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1093\/jac\/dkx175","article-title":"Genetic alterations responsible for reduced susceptibility to vancomycin in community-associated MRSA strains of ST72","volume":"72","author":"Baek","year":"2017","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"1","key":"10.1016\/bs.ampbs.2024.04.006_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s40121-014-0023-0","article-title":"Observation of \u201cseesaw effect\u201d with vancomycin, teicoplanin, daptomycin and ceftaroline in 150 unique MRSA strains","volume":"3","author":"Barber","year":"2014","journal-title":"Infectious Diseases and Therapy"},{"issue":"6","key":"10.1016\/bs.ampbs.2024.04.006_bib702","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1099\/jmm.0.000988","article-title":"Reduced vancomycin susceptibility and increased macrophage survival in Staphylococcus aureus strains sequentially isolated from a bacteraemic patient during a short course of antibiotic therapy","volume":"68","author":"Basco","year":"2019","journal-title":"Journal of Medical Microbiology"},{"key":"10.1016\/bs.ampbs.2024.04.006_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2020.104628","article-title":"The effect of subinhibitory concentration of chlorhexidine on the evolution of vancomycin-intermediate Staphylococcus aureus and the induction of mutations in walKR and vraTSR systems","volume":"87","author":"Baseri","year":"2021","journal-title":"Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases"},{"issue":"8","key":"10.1016\/bs.ampbs.2024.04.006_bib7","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1128\/AAC.00970-15","article-title":"Frequency and distribution of single-nucleotide polymorphisms within mprF in methicillin-resistant Staphylococcus aureus clinical isolates and their role in cross-resistance to daptomycin and host defense antimicrobial peptides","volume":"59","author":"Bayer","year":"2015","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"3","key":"10.1016\/bs.ampbs.2024.04.006_bib8","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1128\/AAC.39.3.781","article-title":"Dimerization and membrane anchors in extracellular targeting of vancomycin group antibiotics","volume":"39","author":"Beauregard","year":"1995","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"12","key":"10.1016\/bs.ampbs.2024.04.006_bib9","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1093\/jac\/dku297","article-title":"Generation of a vancomycin-intermediate Staphylococcus aureus (VISA) strain by two amino acid exchanges in VraS","volume":"69","author":"Berscheid","year":"2014","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"1","key":"10.1016\/bs.ampbs.2024.04.006_bib10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/genes13010034","article-title":"Two-component systems of S. aureus: Signaling and sensing mechanisms","volume":"13","author":"Bleul","year":"2021","journal-title":"Genes"},{"issue":"5","key":"10.1016\/bs.ampbs.2024.04.006_bib11","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/med.1014","article-title":"Vancomycin, teicoplanin, and ramoplanin: Synthetic and mechanistic studies","volume":"21","author":"Boger","year":"2001","journal-title":"Medicinal Research Reviews"},{"issue":"6","key":"10.1016\/bs.ampbs.2024.04.006_bib12","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1089\/mdr.2017.0299","article-title":"Burden of rifampicin- and methicillin-resistant Staphylococcus aureus in Italy","volume":"24","author":"Bongiorno","year":"2018","journal-title":"Microbial Drug Resistance (Larchmont, N. Y.)"},{"issue":"1","key":"10.1016\/bs.ampbs.2024.04.006_bib13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1128\/AAC.01651-12","article-title":"VraT\/YvqF is required for methicillin resistance and activation of the VraSR regulon in Staphylococcus aureus","volume":"57","author":"Boyle-Vavra","year":"2013","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"4","key":"10.1016\/bs.ampbs.2024.04.006_bib14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrd2004","article-title":"Lipid II as a target for antibiotics","volume":"5","author":"Breukink","year":"2006","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/bs.ampbs.2024.04.006_bib15","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-micro-092412-155620","article-title":"Wall teichoic acids of Gram-positive bacteria","volume":"67","author":"Brown","year":"2013","journal-title":"Annual Review of Microbiology"},{"issue":"43","key":"10.1016\/bs.ampbs.2024.04.006_bib16","doi-asserted-by":"crossref","first-page":"10408","DOI":"10.1021\/bi00107a007","article-title":"Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: Biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA","volume":"30","author":"Bugg","year":"1991","journal-title":"Biochemistry"},{"issue":"11","key":"10.1016\/bs.ampbs.2024.04.006_bib951","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1093\/infdis\/jis252","article-title":"Serine\/threonine phosphatase Stp1 contributes to reduced susceptibility to vancomycin and virulence in Staphylococcus aureus","volume":"205","author":"Cameron","year":"2012","journal-title":"The Journal of Infectious Diseases"},{"issue":"1","key":"10.1016\/bs.ampbs.2024.04.006_bib17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bbrc.2014.03.128","article-title":"A novel mode of regulation of the Staphylococcus aureus vancomycin-resistance-associated response regulator VraR mediated by Stk1 protein phosphorylation","volume":"447","author":"Canova","year":"2014","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"9","key":"10.1016\/bs.ampbs.2024.04.006_bib18","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1128\/AAC.00380-13","article-title":"Clinical outcomes in patients with heterogeneous vancomycin-intermediate Staphylococcus aureus bloodstream infection","volume":"57","author":"Casapao","year":"2013","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/bs.ampbs.2024.04.006_bib19","unstructured":"Centers for Disease Control and Prevention (CDC). (2002). Staphylococcus aureus resistant to vancomycin\u2014United States, 2002. MMWR. Morbidity and Mortality Weekly Report, 51(26), 565\u2013567."},{"issue":"20","key":"10.1016\/bs.ampbs.2024.04.006_bib20","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1128\/JB.00544-13","article-title":"Staphylococcus aureus mutants lacking the LytR-CpsA-Psr family of enzymes release cell wall teichoic acids into the extracellular medium","volume":"195","author":"Chan","year":"2013","journal-title":"Journal of Bacteriology"},{"issue":"3","key":"10.1016\/bs.ampbs.2024.04.006_bib21","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/381093","article-title":"Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus","volume":"38","author":"Charles","year":"2004","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1016\/bs.ampbs.2024.04.006_bib810","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/jac\/dkt395","article-title":"Reduced susceptibility to vancomycin in isogenic Staphylococcus aureus strains of sequence type 59: Tracking evolution and identifying mutations by whole-genome sequencing","volume":"69","author":"Chen","year":"2014","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"11","key":"10.1016\/bs.ampbs.2024.04.006_bib22","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1093\/jac\/dkv225","article-title":"Multiple pathways of cross-resistance to glycopeptides and daptomycin in persistent MRSA bacteraemia","volume":"70","author":"Chen","year":"2015","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/bs.ampbs.2024.04.006_bib23","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.3389\/fmicb.2018.01086","article-title":"Effect of a point mutation in mprF on susceptibility to daptomycin, vancomycin, and oxacillin in an MRSA clinical strain","volume":"9","author":"Chen","year":"2018","journal-title":"Frontiers in Microbiology"},{"issue":"12","key":"10.1016\/bs.ampbs.2024.04.006_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1008543","article-title":"PremPS: Predicting the impact of missense mutations on protein stability","volume":"16","author":"Chen","year":"2020","journal-title":"PLoS Computational Biology"},{"issue":"12","key":"10.1016\/bs.ampbs.2024.04.006_bib25","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1128\/IAI.02480-14","article-title":"Site-specific mutation of the sensor kinase GraS in Staphylococcus aureus alters the adaptive response to distinct cationic antimicrobial peptides","volume":"82","author":"Cheung","year":"2014","journal-title":"Infection and Immunity"},{"issue":"3","key":"10.1016\/bs.ampbs.2024.04.006_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009338","article-title":"The extracellular loop of the membrane permease VraG interacts with GraS to sense cationic antimicrobial peptides in Staphylococcus aureus","volume":"17","author":"Cho","year":"2021","journal-title":"PLoS Pathogens"},{"issue":"8","key":"10.1016\/bs.ampbs.2024.04.006_bib27","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S1473-3099(13)70136-1","article-title":"Molecular epidemiology of community-associated methicillin-resistant Staphylococcus aureus in Asia","volume":"13","author":"Chuang","year":"2013","journal-title":"The Lancet Infectious Diseases"},{"key":"10.1016\/bs.ampbs.2024.04.006_bib28","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard","year":"2009"},{"issue":"7341","key":"10.1016\/bs.ampbs.2024.04.006_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/472032a","article-title":"Fix the antibiotics pipeline","volume":"472","author":"Cooper","year":"2011","journal-title":"Nature"},{"issue":"3","key":"10.1016\/bs.ampbs.2024.04.006_bib30","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1469-0691.2009.02740.x","article-title":"Forthcoming therapeutic perspectives for infections due to multidrug-resistant Gram-positive pathogens","volume":"15","author":"Cornaglia","year":"2009","journal-title":"Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"key":"10.1016\/bs.ampbs.2024.04.006_bib31","article-title":"The evolution of diverse antimicrobial responses in vancomycin-intermediate Staphylococcus aureus and its therapeutic implications","author":"Crozier","year":"2024","journal-title":"bioRxiv: The Preprint Server for Biology"},{"issue":"5","key":"10.1016\/bs.ampbs.2024.04.006_bib32","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/lam.13456","article-title":"Cell wall thickness and the molecular mechanism of heterogeneous vancomycin\u2010intermediate Staphylococcus aureus","volume":"72","author":"Cui","year":"2021","journal-title":"Letters in Applied Microbiology"},{"issue":"12","key":"10.1016\/bs.ampbs.2024.04.006_bib33","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1128\/AAC.00437-10","article-title":"An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus","volume":"54","author":"Cui","year":"2010","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"1","key":"10.1016\/bs.ampbs.2024.04.006_bib34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1128\/JCM.41.1.5-14.2003","article-title":"Cell wall thickening Is a common feature of vancomycin resistance in Staphylococcus aureus","volume":"41","author":"Cui","year":"2003","journal-title":"Journal of Clinical Microbiology"},{"issue":"9","key":"10.1016\/bs.ampbs.2024.04.006_bib35","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1128\/AAC.44.9.2276-2285.2000","article-title":"Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50","volume":"44","author":"Cui","year":"2000","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"3","key":"10.1016\/bs.ampbs.2024.04.006_bib36","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1128\/AAC.01173-08","article-title":"Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus","volume":"53","author":"Cui","year":"2009","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"3","key":"10.1016\/bs.ampbs.2024.04.006_bib37","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1128\/AAC.50.3.1079-1082.2006","article-title":"Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus","volume":"50","author":"Cui","year":"2006","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"10","key":"10.1016\/bs.ampbs.2024.04.006_bib38","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1128\/IAI.00195-12","article-title":"The WalKR system controls major staphylococcal virulence genes and is involved in triggering the host inflammatory response","volume":"80","author":"Delaun\u00e9","year":"2012","journal-title":"Infection and Immunity"},{"issue":"5","key":"10.1016\/bs.ampbs.2024.04.006_bib39","doi-asserted-by":"crossref","first-page":"e0256722","DOI":"10.1128\/spectrum.02567-22","article-title":"Cervimycin-resistant Staphylococcus aureus strains display vancomycin-intermediate resistant phenotypes","volume":"10","author":"Dietrich","year":"2022","journal-title":"Microbiology Spectrum"},{"issue":"22","key":"10.1016\/bs.ampbs.2024.04.006_bib40","doi-asserted-by":"crossref","first-page":"8257","DOI":"10.1128\/JB.00645-07","article-title":"New insights into the WalK\/WalR (YycG\/YycF) essential signal transduction pathway reveal a major role in controlling cell wall metabolism and biofilm formation in Staphylococcus aureus","volume":"189","author":"Dubrac","year":"2007","journal-title":"Journal of Bacteriology"},{"issue":"4","key":"10.1016\/bs.ampbs.2024.04.006_bib41","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1128\/JB.186.4.1175-1181.2004","article-title":"Identification of genes controlled by the essential YycG\/YycF two-component system of Staphylococcus aureus","volume":"186","author":"Dubrac","year":"2004","journal-title":"Journal of Bacteriology"},{"issue":"Pt 4","key":"10.1016\/bs.ampbs.2024.04.006_bib42","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1107\/S0907444912050469","article-title":"Structure of the complex between teicoplanin and a bacterial cell-wall peptide: Use of a carrier-protein approach","volume":"69","author":"Economou","year":"2013","journal-title":"Acta Crystallographica Section D: Biological Crystallography"},{"issue":"9","key":"10.1016\/bs.ampbs.2024.04.006_bib43","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00228-012-1259-9","article-title":"Vancomycin-induced nephrotoxicity: Mechanism, incidence, risk factors and special populations. A literature review","volume":"68","author":"Elyasi","year":"2012","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1016\/bs.ampbs.2024.04.006_bib44","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02340-14","article-title":"The lipid-modifying multiple peptide resistance factor Is an oligomer consisting of distinct interacting synthase and flippase subunits","volume":"6","author":"Ernst","year":"2015","journal-title":"mBio"},{"key":"10.1016\/bs.ampbs.2024.04.006_bib45","unstructured":"EUCAST. (2024).\u00a0The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 14.0, 2024.\u00a0http:\/\/www.eucast.org."},{"issue":"16","key":"10.1016\/bs.ampbs.2024.04.006_bib46","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1016\/j.cub.2023.06.082","article-title":"Evolutionary history of Staphylococcus aureus influences antibiotic resistance evolution","volume":"33","author":"Fait","year":"2023","journal-title":"Current Biology"},{"issue":"30","key":"10.1016\/bs.ampbs.2024.04.006_bib47","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2118262119","article-title":"Adaptive laboratory evolution and independent component analysis disentangle complex vancomycin adaptation trajectories","volume":"119","author":"Fait","year":"2022","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"2","key":"10.1016\/bs.ampbs.2024.04.006_bib48","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1128\/AAC.05054-11","article-title":"GraXSR proteins interact with the VraFG ABC transporter to form a five-component system required for cationic antimicrobial peptide sensing and resistance in Staphylococcus aureus","volume":"56","author":"Falord","year":"2012","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"7","key":"10.1016\/bs.ampbs.2024.04.006_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021323","article-title":"Investigation of the Staphylococcus aureus GraSR regulon reveals novel links to virulence, stress response and cell wall signal transduction pathways","volume":"6","author":"Falord","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/bs.ampbs.2024.04.006_bib50","doi-asserted-by":"crossref","first-page":"e0016222","DOI":"10.1128\/jb.00162-22","article-title":"Revisiting the role of VraTSR in Staphylococcus aureus response to cell wall-targeting antibiotics","volume":"204","author":"Fernandes","year":"2022","journal-title":"Journal of Bacteriology"},{"issue":"11","key":"10.1016\/bs.ampbs.2024.04.006_bib51","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1128\/AAC.45.11.3070-3075.2001","article-title":"Role of penicillin-binding protein 4 in expression of vancomycin resistance among clinical isolates of oxacillin-resistant Staphylococcus aureus","volume":"45","author":"Finan","year":"2001","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"6","key":"10.1016\/bs.ampbs.2024.04.006_bib52","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1128\/AAC.01702-08","article-title":"Fitness cost of VanA-type vancomycin resistance in methicillin-resistant Staphylococcus aureus","volume":"53","author":"Foucault","year":"2009","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"1","key":"10.1016\/bs.ampbs.2024.04.006_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-69962-4","article-title":"Human antimicrobial peptide, LL-37, induces non-inheritable reduced susceptibility to vancomycin in Staphylococcus aureus","volume":"10","author":"Friberg","year":"2020","journal-title":"Scientific Reports"},{"issue":"45","key":"10.1016\/bs.ampbs.2024.04.006_bib54","doi-asserted-by":"crossref","first-page":"7975","DOI":"10.1021\/bi401177n","article-title":"Two unique phosphorylation-driven signaling pathways crosstalk in Staphylococcus aureus to modulate the cell-wall charge: Stk1\/Stp1 meets GraSR","volume":"52","author":"Fridman","year":"2013","journal-title":"Biochemistry"},{"issue":"8","key":"10.1016\/bs.ampbs.2024.04.006_bib55","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1080\/14787210.2017.1358611","article-title":"Epidemiology and clinical relevance of Staphylococcus aureus intestinal carriage: A systematic review and meta-analysis","volume":"15","author":"Gagnaire","year":"2017","journal-title":"Expert Review of Anti-Infective Therapy"},{"issue":"6","key":"10.1016\/bs.ampbs.2024.04.006_bib600","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000944","article-title":"Two novel point mutations in clinical Staphylococcus aureus reduce linezolid susceptibility and switch on the stringent response to promote persistent infection","volume":"6","author":"Gao","year":"2010","journal-title":"PLoS Pathogens"},{"issue":"6","key":"10.1016\/bs.ampbs.2024.04.006_bib56","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/infdis\/jis772","article-title":"The RpoB H481Y rifampicin resistance mutation and an active stringent response reduce virulence and increase resistance to innate immune responses in Staphylococcus aureus","volume":"207","author":"Gao","year":"2013","journal-title":"The Journal of Infectious Diseases"},{"issue":"2","key":"10.1016\/bs.ampbs.2024.04.006_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002505","article-title":"Genetic pathway in acquisition and loss of vancomycin resistance in a methicillin resistant Staphylococcus aureus (MRSA) strain of clonal type USA300","volume":"8","author":"Gardete","year":"2012","journal-title":"PLoS Pathogens"},{"issue":"10","key":"10.1016\/bs.ampbs.2024.04.006_bib58","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1128\/AAC.00356-06","article-title":"Role of VraSR in antibiotic resistance and antibiotic-induced stress response in Staphylococcus aureus","volume":"50","author":"Gardete","year":"2006","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"1","key":"10.1016\/bs.ampbs.2024.04.006_bib59","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01608-17","article-title":"Metabolic mitigation of Staphylococcus aureus vancomycin intermediate-level susceptibility","volume":"62","author":"Gardner","year":"2017","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/bs.ampbs.2024.04.006_bib700","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-018-0574-x","article-title":"Genomic exploration of sequential clinical isolates reveals a distinctive molecular signature of persistent Staphylococcus aureus bacteraemia","volume":"10","author":"Giulieri","year":"2018","journal-title":"Genome Medicine"},{"issue":"5","key":"10.1016\/bs.ampbs.2024.04.006_bib60","first-page":"928","article-title":"Adaptive laboratory evolution of Staphylococcus aureus resistance to vancomycin and daptomycin: Mutation patterns and cross-resistance","volume":"12","author":"Gostev","year":"2023","journal-title":"Antibiotics (Basel, Switzerland)"},{"key":"10.1016\/bs.ampbs.2024.04.006_bib61","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.2147\/IDR.S336200","article-title":"Molecular characteristics of rifampin-sensitive and -resistant isolates and characteristics of rpoB gene mutations in methicillin-resistant Staphylococcus aureus","volume":"14","author":"Guo","year":"2021","journal-title":"Infection and Drug Resistance"},{"issue":"Pt 8","key":"10.1016\/bs.ampbs.2024.04.006_bib62","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1099\/jmm.0.05210-0","article-title":"Alterations in phage-typing patterns in vancomycin-intermediate Staphylococcus aureus","volume":"52","author":"Gustafson","year":"2003","journal-title":"Journal of Medical Microbiology"},{"issue":"1","key":"10.1016\/bs.ampbs.2024.04.006_bib63","doi-asserted-by":"crossref","first-page":"e02268-14","DOI":"10.1128\/mBio.02268-14","article-title":"Reversible antibiotic tolerance induced in Staphylococcus aureus by concurrent drug exposure","volume":"6","author":"Haaber","year":"2015","journal-title":"mBio"},{"issue":"11","key":"10.1016\/bs.ampbs.2024.04.006_bib64","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.1128\/AAC.01139-12","article-title":"Contribution of selected gene mutations to resistance in clinical isolates of vancomycin-intermediate Staphylococcus aureus","volume":"56","author":"Hafer","year":"2012","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"2","key":"10.1016\/bs.ampbs.2024.04.006_bib65","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/jac\/42.2.199","article-title":"Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50","volume":"42","author":"Hanaki","year":"1998","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"2","key":"10.1016\/bs.ampbs.2024.04.006_bib66","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1128\/jb.158.2.513-516.1984","article-title":"Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus","volume":"158","author":"Hartman","year":"1984","journal-title":"Journal of Bacteriology"},{"issue":"5793","key":"10.1016\/bs.ampbs.2024.04.006_bib67","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1126\/science.1129818","article-title":"An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II","volume":"313","author":"Hasper","year":"2006","journal-title":"Science (New York, N. Y.)"},{"issue":"1","key":"10.1016\/bs.ampbs.2024.04.006_bib952","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3390\/antibiotics4010076","article-title":"Genomic, transcriptomic and metabolomic studies of two well-characterized, laboratory-derived vancomycin-intermediate Staphylococcus aureus strains derived from the same parent strain","volume":"4","author":"Hattangady","year":"2015","journal-title":"Antibiotics"},{"issue":"7","key":"10.1016\/bs.ampbs.2024.04.006_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.0030102","article-title":"Molecular basis of resistance to muramidase and cationic antimicrobial peptide activity of lysozyme in staphylococci","volume":"3","author":"Herbert","year":"2007","journal-title":"PLoS Pathogens"},{"key":"10.1016\/bs.ampbs.2024.04.006_bib960","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkz562","article-title":"Occurrence of cross-resistance and \u03b2-lactam seesaw effect in glycopeptide-, lipopeptide- and lipoglycopeptide-resistant MRSA correlates with membrane phosphatidylglycerol levels","author":"Hines","year":"2020","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"3","key":"10.1016\/bs.ampbs.2024.04.006_bib69","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1473-3099(01)00091-3","article-title":"Vancomycin-resistant Staphylococcus aureus: A new model of antibiotic resistance","volume":"1","author":"Hiramatsu","year":"2001","journal-title":"The Lancet Infectious Diseases"},{"issue":"9092","key":"10.1016\/bs.ampbs.2024.04.006_bib70","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(97)07324-8","article-title":"Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin","volume":"350","author":"Hiramatsu","year":"1997","journal-title":"The Lancet"},{"issue":"1","key":"10.1016\/bs.ampbs.2024.04.006_bib71","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jac\/40.1.135","article-title":"Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility","volume":"40","author":"Hiramatsu","year":"1997","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"8","key":"10.1016\/bs.ampbs.2024.04.006_bib72","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1128\/AAC.01365-08","article-title":"Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA","volume":"53","author":"Horne","year":"2009","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"2","key":"10.1016\/bs.ampbs.2024.04.006_bib73","doi-asserted-by":"crossref","first-page":"e0052821","DOI":"10.1128\/Spectrum.00528-21","article-title":"The role of \u03b2-glycosylated wall teichoic acids in the reduction of vancomycin susceptibility in vancomycin-intermediate Staphylococcus aureus","volume":"9","author":"Hort","year":"2021","journal-title":"Microbiology Spectrum"},{"issue":"1","key":"10.1016\/bs.ampbs.2024.04.006_bib74","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/CMR.00042-09","article-title":"Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: Resistance mechanisms, laboratory detection, and clinical implications","volume":"23","author":"Howden","year":"2010","journal-title":"Clinical Microbiology Reviews"},{"issue":"9","key":"10.1016\/bs.ampbs.2024.04.006_bib75","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1128\/AAC.00422-06","article-title":"Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia","volume":"50","author":"Howden","year":"2006","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"11","key":"10.1016\/bs.ampbs.2024.04.006_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002359","article-title":"Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR","volume":"7","author":"Howden","year":"2011","journal-title":"PLoS Pathogens"},{"key":"10.1016\/bs.ampbs.2024.04.006_bib77","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.meegid.2013.03.047","article-title":"The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous-VISA","volume":"21","author":"Howden","year":"2014","journal-title":"Infection, Genetics and Evolution"},{"key":"10.1016\/bs.ampbs.2024.04.006_bib78","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2180-8-39","article-title":"Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia","volume":"8","author":"Howden","year":"2008","journal-title":"BMC Microbiology"},{"issue":"10","key":"10.1016\/bs.ampbs.2024.04.006_bib79","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1128\/AAC.01613-07","article-title":"Genomic analysis reveals a point mutation in the two-component sensor gene graS that leads to intermediate vancomycin resistance in clinical Staphylococcus aureus","volume":"52","author":"Howden","year":"2008","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"4","key":"10.1016\/bs.ampbs.2024.04.006_bib80","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1086\/381202","article-title":"Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility","volume":"38","author":"Howden","year":"2004","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1016\/bs.ampbs.2024.04.006_bib81","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1128\/AAC.04290-14","article-title":"Mechanism of reduced vancomycin susceptibility conferred by walK mutation in community-acquired methicillin-resistant Staphylococcus aureus strain MW2","volume":"59","author":"Hu","year":"2015","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/bs.ampbs.2024.04.006_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2016.01601","article-title":"Molecular events for promotion of vancomycin resistance in vancomycin intermediate Staphylococcus aureus","volume":"7","author":"Hu","year":"2016","journal-title":"Frontiers in Microbiology"},{"issue":"204","key":"10.1016\/bs.ampbs.2024.04.006_bib83","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006609","article-title":"Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development","volume":"5","author":"Imamovic","year":"2013","journal-title":"Science Translational Medicine"},{"issue":"2","key":"10.1016\/bs.ampbs.2024.04.006_bib84","first-page":"e93","article-title":"High vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistant Staphylococcus aureus infections: A meta-analysis","volume":"17","author":"Jacob","year":"2013","journal-title":"International Journal of Infectious Diseases: IJID: Official Publication of the International Society for Infectious Diseases"},{"issue":"5","key":"10.1016\/bs.ampbs.2024.04.006_bib85","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1021\/cb300007j","article-title":"Redesign of glycopeptide antibiotics \u2013 Back to the future","volume":"7","author":"James","year":"2012","journal-title":"ACS Chemical Biology"},{"issue":"4","key":"10.1016\/bs.ampbs.2024.04.006_bib86","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijmm.2007.02.002","article-title":"Role of insertion elements and yycFG in the development of decreased susceptibility to vancomycin in Staphylococcus aureus","volume":"297","author":"Jansen","year":"2007","journal-title":"International Journal of Medical Microbiology"},{"issue":"6","key":"10.1016\/bs.ampbs.2024.04.006_bib87","first-page":"947","article-title":"Selective bacteriocins: A promising treatment for Staphylococcus aureus skin infections reveals insights into resistant mutants, vancomycin resistance, and cell wall alterations","volume":"12","author":"Jaumaux","year":"2023","journal-title":"Antibiotics (Basel, Switzerland)"},{"key":"10.1016\/bs.ampbs.2024.04.006_bib88","article-title":"Population diversity jeopardizes the efficacy of antibiotic cycling","author":"Jiao","year":"2016","journal-title":"bioRxiv"},{"key":"10.1016\/bs.ampbs.2024.04.006_bib89","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13002","article-title":"The evolution of antimicrobial peptide resistance in Pseudomonas aeruginosa is shaped by strong epistatic interactions","volume":"7","author":"Jochumsen","year":"2016","journal-title":"Nature Communications"},{"issue":"2","key":"10.1016\/bs.ampbs.2024.04.006_bib90","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1021\/cr030103a","article-title":"Glycopeptide and lipoglycopeptide antibiotics","volume":"105","author":"Kahne","year":"2005","journal-title":"Chemical Reviews"},{"issue":"3","key":"10.1016\/bs.ampbs.2024.04.006_bib91","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jhin.2016.08.018","article-title":"Acquired resistance to chlorhexidine\u2014Is it time to establish an \u201cantiseptic stewardship\u201d initiative?","volume":"94","author":"Kampf","year":"2016","journal-title":"The Journal of Hospital Infection"},{"issue":"1","key":"10.1016\/bs.ampbs.2024.04.006_bib92","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13756-022-01140-9","article-title":"Impact of vancomycin use trend change due to the availability of alternative antibiotics on the prevalence of Staphylococcus aureus with reduced vancomycin susceptibility: A 14-year retrospective study","volume":"11","author":"Kang","year":"2022","journal-title":"Antimicrobial Resistance and Infection Control"},{"issue":"8","key":"10.1016\/bs.ampbs.2024.04.006_bib93","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1128\/AAC.00834-08","article-title":"Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem","volume":"53","author":"Katayama","year":"2009","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"6","key":"10.1016\/bs.ampbs.2024.04.006_bib94","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1128\/AAC.00420-16","article-title":"Complete reconstitution of the vancomycin-intermediate Staphylococcus aureus phenotype of strain Mu50 in vancomycin-susceptible S. aureus","volume":"60","author":"Katayama","year":"2016","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"3","key":"10.1016\/bs.ampbs.2024.04.006_bib95","doi-asserted-by":"crossref","first-page":"e0491822","DOI":"10.1128\/spectrum.04918-22","article-title":"Optimization of phage-antibiotic combinations against Staphylococcus aureus biofilms","volume":"11","author":"Kebriaei","year":"2023","journal-title":"Microbiology Spectrum"},{"issue":"1","key":"10.1016\/bs.ampbs.2024.04.006_bib96","doi-asserted-by":"crossref","first-page":"e01863-20","DOI":"10.1128\/AAC.01863-20","article-title":"Bacteriophage AB-SA01 cocktail in combination with antibiotics against MRSA-VISA strain in an in vitro pharmacokinetic\/pharmacodynamic model","volume":"65","author":"Kebriaei","year":"2020","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/bs.ampbs.2024.04.006_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgar.2024.02.002","article-title":"Global distribution of heterogeneous vancomycin-intermediate Staphylococcus aureus strains (1997-2021): A systematic review and meta-analysis","author":"Keikha","year":"2024","journal-title":"Journal of Global Antimicrobial Resistance"},{"issue":"9","key":"10.1016\/bs.ampbs.2024.04.006_bib98","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1080\/17474124.2023.2250716","article-title":"Therapeutics for Clostridioides difficile infection: Molecules and microbes","volume":"17","author":"Khanna","year":"2023","journal-title":"Expert Review of Gastroenterology & Hepatology"},{"issue":"40","key":"10.1016\/bs.ampbs.2024.04.006_bib99","doi-asserted-by":"crossref","first-page":"14494","DOI":"10.1073\/pnas.1409800111","article-title":"Alternating antibiotic treatments constrain evolutionary paths to multidrug resistance","volume":"111","author":"Kim","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/bs.ampbs.2024.04.006_bib100","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3904\/kjim.2016.351","article-title":"Clinical and microbiological factors associated with early patient mortality from methicillin-resistant Staphylococcus aureus bacteremia","volume":"34","author":"Kim","year":"2019","journal-title":"The Korean Journal of Internal Medicine"},{"issue":"10","key":"10.1016\/bs.ampbs.2024.04.006_bib101","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics12101511","article-title":"Molecular characteristics and prevalence of rifampin resistance in Staphylococcus aureus isolates from patients with bacteremia in South Korea","volume":"12","author":"Kim","year":"2023","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/bs.ampbs.2024.04.006_bib102","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF02923549","article-title":"The role of compensatory neutral mutations in molecular evolution","volume":"64","author":"Kimura","year":"1985","journal-title":"Journal of Genetics"},{"issue":"3","key":"10.1016\/bs.ampbs.2024.04.006_bib103","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1128\/CMR.10.3.505","article-title":"Nasal carriage of Staphylococcus aureus: Epidemiology, underlying mechanisms, and associated risks","volume":"10","author":"Kluytmans","year":"1997","journal-title":"Clinical Microbiology Reviews"},{"issue":"5","key":"10.1016\/bs.ampbs.2024.04.006_bib104","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2014.06.046","article-title":"Evolution of resistance to a last-resort antibiotic in Staphylococcus aureus via bacterial competition","volume":"158","author":"Koch","year":"2014","journal-title":"Cell"},{"issue":"2","key":"10.1016\/bs.ampbs.2024.04.006_bib105","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.chom.2019.01.014","article-title":"Phage therapy: A renewed approach to combat antibiotic-resistant bacteria","volume":"25","author":"Kortright","year":"2019","journal-title":"Cell Host & Microbe"},{"issue":"4","key":"10.1016\/bs.ampbs.2024.04.006_bib106","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0021-9258(17)38141-3","article-title":"A membrane enzyme from Staphylococcus aureus which catalyzes transpeptidase, carboxypeptidase, and penicillinase activities","volume":"253","author":"Kozarich","year":"1978","journal-title":"Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/bs.ampbs.2024.04.006_bib107","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1046\/j.1365-2958.2003.03599.x","article-title":"Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus","volume":"49","author":"Kuroda","year":"2003","journal-title":"Molecular Microbiology"},{"issue":"2","key":"10.1016\/bs.ampbs.2024.04.006_bib108","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1006\/bbrc.2000.2277","article-title":"Identification of the up- and down-regulated genes in vancomycin-resistant Staphylococcus aureus strains Mu3 and Mu50 by cDNA differential hybridization method","volume":"269","author":"Kuroda","year":"2000","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/bs.ampbs.2024.04.006_bib109","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.3389\/fmicb.2019.01882","article-title":"IS256-mediated overexpression of the WalKR two-component system regulon contributes to reduced vancomycin susceptibility in a Staphylococcus aureus clinical isolate","volume":"10","author":"Kuroda","year":"2019","journal-title":"Frontiers in Microbiology"},{"key":"10.1016\/bs.ampbs.2024.04.006_bib110","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/msb.2013.57","article-title":"Bacterial evolution of antibiotic hypersensitivity","volume":"9","author":"L\u00e1z\u00e1r","year":"2013","journal-title":"Molecular Systems Biology"},{"issue":"1","key":"10.1016\/bs.ampbs.2024.04.006_bib111","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-29717-3","article-title":"Human serum triggers antibiotic tolerance in Staphylococcus aureus","volume":"13","author":"Ledger","year":"2022","journal-title":"Nature Communications"},{"key":"10.1016\/bs.ampbs.2024.04.006_bib112","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jgar.2021.12.005","article-title":"Rifamycin resistance, rpoB gene mutation and clinical outcomes of Staphylococcus species isolates from prosthetic joint infections in Republic of Korea","volume":"28","author":"Lee","year":"2022","journal-title":"Journal of Global Antimicrobial Resistance"},{"issue":"1","key":"10.1016\/bs.ampbs.2024.04.006_bib113","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/v11010088","article-title":"Design and preclinical development of a phage product for the treatment of antibiotic-resistant Staphylococcus aureus infections","volume":"11","author":"Lehman","year":"2019","journal-title":"Viruses"},{"issue":"10","key":"10.1016\/bs.ampbs.2024.04.006_bib114","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1128\/AAC.47.10.3040-3045.2003","article-title":"Staphylococcus aureus with heterogeneous resistance to vancomycin: Epidemiology, clinical significance, and critical assessment of diagnostic methods","volume":"47","author":"Liu","year":"2003","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"9","key":"10.1016\/bs.ampbs.2024.04.006_bib115","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1128\/AAC.00113-08","article-title":"Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin","volume":"52","author":"Lodise","year":"2008","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"8","key":"10.1016\/bs.ampbs.2024.04.006_bib116","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJM199808203390806","article-title":"Staphylococcus aureus infections","volume":"339","author":"Lowy","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1016\/bs.ampbs.2024.04.006_bib117","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1172\/JCI18535","article-title":"Antimicrobial resistance: The example of Staphylococcus aureus","volume":"111","author":"Lowy","year":"2003","journal-title":"Journal of Clinical Investigation"},{"issue":"1","key":"10.1016\/bs.ampbs.2024.04.006_bib118","article-title":"Modulation of MRSA virulence gene expression by the wall teichoic acid enzyme TarO","volume":"14","author":"Lu","year":"2023","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/bs.ampbs.2024.04.006_bib119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-021-02339-z","article-title":"Environmental conditions dictate differential evolution of vancomycin resistance in Staphylococcus aureus","volume":"4","author":"Machado","year":"2021","journal-title":"Communications Biology"},{"issue":"12","key":"10.1016\/bs.ampbs.2024.04.006_bib120","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1128\/AAC.00425-13","article-title":"Comprehensive identification of mutations responsible for heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA)-to-VISA conversion in laboratory-generated VISA strains derived from hVISA clinical strain Mu3","volume":"57","author":"Matsuo","year":"2013","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"9","key":"10.1016\/bs.ampbs.2024.04.006_bib121","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1128\/AAC.00398-11","article-title":"Mutation of RNA polymerase \u03b2 subunit (rpoB) promotes hVISA-to-VISA phenotypic conversion of strain Mu3\u2207","volume":"55","author":"Matsuo","year":"2011","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"3","key":"10.1016\/bs.ampbs.2024.04.006_bib122","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1128\/JB.188.3.1120-1133.2006","article-title":"Overexpression of genes of the cell wall stimulon in clinical isolates of Staphylococcus aureus exhibiting vancomycin-intermediate- S. aureus-type resistance to vancomycin","volume":"188","author":"McAleese","year":"2006","journal-title":"Journal of Bacteriology"},{"issue":"7","key":"10.1016\/bs.ampbs.2024.04.006_bib123","doi-asserted-by":"crossref","DOI":"10.1128\/aac.02247-21","article-title":"Antibiotic exposure leads to reduced phage susceptibility in vancomycin intermediate Staphylococcus aureus (VISA)","volume":"66","author":"McCallin","year":"2022","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"9","key":"10.1016\/bs.ampbs.2024.04.006_bib124","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1111\/1462-2920.14310","article-title":"Metagenome analysis of Russian and Georgian Pyophage cocktails and a placebo-controlled safety trial of single phage versus phage cocktail in healthy Staphylococcus aureus carriers","volume":"20","author":"McCallin","year":"2018","journal-title":"Environmental Microbiology"},{"issue":"4","key":"10.1016\/bs.ampbs.2024.04.006_bib125","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1128\/AAC.01213-10","article-title":"Mutational analyses of open reading frames within the vraSR operon and their roles in the cell wall stress response of Staphylococcus aureus","volume":"55","author":"McCallum","year":"2011","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"7","key":"10.1016\/bs.ampbs.2024.04.006_bib126","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1128\/AAC.00279-13","article-title":"Decreased vancomycin susceptibility in Staphylococcus aureus caused by IS256 tempering of WalKR expression","volume":"57","author":"McEvoy","year":"2013","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"2","key":"10.1016\/bs.ampbs.2024.04.006_bib127","first-page":"269","article-title":"Vancomycin resistance in Staphylococcus aureus","volume":"90","author":"McGuinness","year":"2017","journal-title":"The Yale Journal of Biology and Medicine"},{"issue":"8","key":"10.1016\/bs.ampbs.2024.04.006_bib128","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1128\/AAC.00209-07","article-title":"Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus","volume":"51","author":"Meehl","year":"2007","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"1","key":"10.1016\/bs.ampbs.2024.04.006_bib129","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/jac\/dkm445","article-title":"Microbiological effects of prior vancomycin use in patients with methicillin-resistant Staphylococcus aureus bacteraemia","volume":"61","author":"Moise","year":"2008","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"4","key":"10.1016\/bs.ampbs.2024.04.006_bib130","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1128\/AAC.47.4.1262-1266.2003","article-title":"Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis","volume":"47","author":"Moore","year":"2003","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"10325","key":"10.1016\/bs.ampbs.2024.04.006_bib131","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"The Lancet"},{"issue":"22","key":"10.1016\/bs.ampbs.2024.04.006_bib132","doi-asserted-by":"crossref","first-page":"9451","DOI":"10.1073\/pnas.0609839104","article-title":"Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing","volume":"104","author":"Mwangi","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/bs.ampbs.2024.04.006_bib133","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1128\/AAC.01057-06","article-title":"Vancomycin-intermediate Staphylococcus aureus strains have impaired acetate catabolism: Implications for polysaccharide intercellular adhesin synthesis and autolysis","volume":"51","author":"Nelson","year":"2007","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"4","key":"10.1016\/bs.ampbs.2024.04.006_bib134","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1128\/MMBR.67.4.686-723.2003","article-title":"A continuum of anionic charge: Structures and functions of d-alanyl-teichoic acids in Gram-positive bacteria","volume":"67","author":"Neuhaus","year":"2003","journal-title":"Microbiology and Molecular Biology Reviews: MMBR"},{"issue":"1","key":"10.1016\/bs.ampbs.2024.04.006_bib135","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12859-021-04137-0","article-title":"Predicting rifampicin resistance mutations in bacterial RNA polymerase subunit beta based on majority consensus","volume":"22","author":"Ning","year":"2021","journal-title":"BMC Bioinformatics"},{"issue":"12","key":"10.1016\/bs.ampbs.2024.04.006_bib136","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1128\/AAC.48.12.4800-4807.2004","article-title":"Reduced content of lysyl-phosphatidylglycerol in the cytoplasmic membrane affects susceptibility to moenomycin, as well as vancomycin, gentamicin, and antimicrobial peptides, in Staphylococcus aureus","volume":"48","author":"Nishi","year":"2004","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"1","key":"10.1016\/bs.ampbs.2024.04.006_bib137","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/AAC.50.1.298-309.2006","article-title":"Molecular genetic and structural modeling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampin resistance genotypes in relation to clinical prevalence","volume":"50","author":"O\u2019Neill","year":"2006","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"3","key":"10.1016\/bs.ampbs.2024.04.006_bib138","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.drup.2013.10.002","article-title":"Reduced glycopeptide and lipopeptide susceptibility in Staphylococcus aureus and the \u201cseesaw effect\u201d: Taking advantage of the back door left open?","volume":"16","author":"Ortwine","year":"2013","journal-title":"Drug Resistance Updates"},{"issue":"11","key":"10.1016\/bs.ampbs.2024.04.006_bib139","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1086\/504084","article-title":"An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus","volume":"42","author":"Patel","year":"2006","journal-title":"Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America"},{"issue":"4","key":"10.1016\/bs.ampbs.2024.04.006_bib801","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1086\/596511","article-title":"Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection","volume":"199","author":"Peleg","year":"2009","journal-title":"The Journal of Infectious Diseases"},{"issue":"1","key":"10.1016\/bs.ampbs.2024.04.006_bib140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028316","article-title":"Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureus","volume":"7","author":"Peleg","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/bs.ampbs.2024.04.006_bib701","first-page":"1006","article-title":"WalK(S221P), a naturally occurring mutation, confers vancomycin resistance in VISA strain XN108","volume":"72","author":"Peng","year":"2017","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"13","key":"10.1016\/bs.ampbs.2024.04.006_bib141","doi-asserted-by":"crossref","first-page":"8405","DOI":"10.1074\/jbc.274.13.8405","article-title":"Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides","volume":"274","author":"Peschel","year":"1999","journal-title":"The Journal of Biological Chemistry"},{"issue":"10","key":"10.1016\/bs.ampbs.2024.04.006_bib142","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1128\/AAC.44.10.2845-2847.2000","article-title":"The d-alanine residues of Staphylococcus aureus teichoic acids alter the susceptibility to vancomycin and the activity of autolytic enzymes","volume":"44","author":"Peschel","year":"2000","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"8","key":"10.1016\/bs.ampbs.2024.04.006_bib143","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1128\/AAC.46.8.2595-2601.2002","article-title":"In vitro and in vivo activities of tigecycline (GAR-936), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant Gram-positive pathogens","volume":"46","author":"Petersen","year":"2002","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"2","key":"10.1016\/bs.ampbs.2024.04.006_bib953","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1128\/AAC.44.2.294-303.2000","article-title":"Characterization of passage-selected vancomycin-resistant Staphylococcus aureus strains of diverse parental backgrounds","volume":"44","author":"Pfeltz","year":"2000","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"11","key":"10.1016\/bs.ampbs.2024.04.006_bib144","doi-asserted-by":"crossref","DOI":"10.1038\/nrg2452","article-title":"Epistasis\u2014The essential role of gene interactions in the structure and evolution of genetic systems","volume":"9","author":"Phillips","year":"2008","journal-title":"Nature Reviews. Genetics"},{"issue":"7728","key":"10.1016\/bs.ampbs.2024.04.006_bib145","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41586-018-0616-y","article-title":"Pathogen elimination by probiotic Bacillus via signaling interference.","volume":"562","author":"Piewngam","year":"2018","journal-title":"Nature"},{"issue":"8","key":"10.1016\/bs.ampbs.2024.04.006_bib786","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1086\/605636","article-title":"Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus","volume":"49","author":"Pillai","year":"2009","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1016\/bs.ampbs.2024.04.006_bib146","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1365-2958.2004.04420.x","article-title":"Recruitment of penicillin-binding protein PBP2 to the division site of Staphylococcus aureus is dependent on its transpeptidation substrates","volume":"55","author":"Pinho","year":"2005","journal-title":"Molecular Microbiology"},{"issue":"1","key":"10.1016\/bs.ampbs.2024.04.006_bib147","doi-asserted-by":"crossref","first-page":"18120","DOI":"10.1038\/s41598-020-74648-y","article-title":"Prediction of rifampicin resistance beyond the RRDR using structure-based machine learning approaches","volume":"10","author":"Portelli","year":"2020","journal-title":"Scientific Reports"},{"issue":"12","key":"10.1016\/bs.ampbs.2024.04.006_bib148","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1128\/AAC.00904-08","article-title":"Vancomycin MICs for methicillin-resistant Staphylococcus aureus isolates differ based upon the susceptibility test method used","volume":"52","author":"Prakash","year":"2008","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/bs.ampbs.2024.04.006_bib149","first-page":"1","article-title":"Envelope structures of Gram-positive bacteria","volume":"404","author":"Rajagopal","year":"2017","journal-title":"Current Topics in Microbiology and Immunology"},{"issue":"6","key":"10.1016\/bs.ampbs.2024.04.006_bib950","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021577","article-title":"Whole genome sequencing and complete genetic analysis reveals novel pathways to glycopeptide resistance in Staphylococcus aureus","volume":"6","author":"Renzoni","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/bs.ampbs.2024.04.006_bib150","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1128\/AAC.01287-08","article-title":"Identification by genomic and genetic analysis of two new genes playing a key role in intermediate glycopeptide resistance in Staphylococcus aureus","volume":"53","author":"Renzoni","year":"2009","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"9","key":"10.1016\/bs.ampbs.2024.04.006_bib151","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1128\/AAC.02574-14","article-title":"Exposure of Staphylococcus aureus to subinhibitory concentrations of \u03b2-lactam antibiotics induces heterogeneous vancomycin-intermediate Staphylococcus aureus","volume":"58","author":"Roch","year":"2014","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/bs.ampbs.2024.04.006_bib152","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.02303","article-title":"Daptomycin resistance in clinical MRSA strains is associated with a high biological fitness cost","volume":"8","author":"Roch","year":"2017","journal-title":"Frontiers in Microbiology"},{"key":"10.1016\/bs.ampbs.2024.04.006_bib153","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2014.00217","article-title":"Vancomycin revisited \u2013 60 years later","volume":"2","author":"Rubinstein","year":"2014","journal-title":"Frontiers in Public Health"},{"issue":"2","key":"10.1016\/bs.ampbs.2024.04.006_bib154","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0304-4165(03)00028-X","article-title":"Inactivation of mprF affects vancomycin susceptibility in Staphylococcus aureus","volume":"1621","author":"Ruzin","year":"2003","journal-title":"Biochimica et Biophysica Acta"},{"issue":"9","key":"10.1016\/bs.ampbs.2024.04.006_bib155","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1128\/JCM.00582-08","article-title":"Characterization of vancomycin-heteroresistant Staphylococcus aureus from the metropolitan area of Detroit, Michigan, over a 22-year period (1986 to 2007)","volume":"46","author":"Rybak","year":"2008","journal-title":"Journal of Clinical Microbiology"},{"issue":"5","key":"10.1016\/bs.ampbs.2024.04.006_bib156","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1093\/jac\/dkp319","article-title":"Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals","volume":"64","author":"Sader","year":"2009","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"issue":"7","key":"10.1016\/bs.ampbs.2024.04.006_bib157","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1128\/AAC.00093-09","article-title":"Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus","volume":"53","author":"Sader","year":"2009","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"5","key":"10.1016\/bs.ampbs.2024.04.006_bib800","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1128\/AAC.46.5.1492-1502.2002","article-title":"Accessory gene regulator (AGR) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin","volume":"46","author":"Sakoulas","year":"2002","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"2","key":"10.1016\/bs.ampbs.2024.04.006_bib158","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.diagmicrobio.2018.09.003","article-title":"VISA \u2013\u00a0Daptomycin non-susceptible Staphylococcus aureus frequently demonstrate non-susceptibility to Telavancin","volume":"93","author":"Saravolatz","year":"2019","journal-title":"Diagnostic Microbiology and Infectious Disease"},{"issue":"7","key":"10.1016\/bs.ampbs.2024.04.006_bib159","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ijmm.2008.01.011","article-title":"Mode of action of human \u03b2-defensin 3 against Staphylococcus aureus and transcriptional analysis of responses to defensin challenge","volume":"298","author":"Sass","year":"2008","journal-title":"International Journal of Medical Microbiology"},{"issue":"6","key":"10.1016\/bs.ampbs.2024.04.006_bib160","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3201\/eid0906.030001","article-title":"Clinical significance of varying degrees of vancomycin susceptibility in methicillin-resistant Staphylococcus aureus bacteremia","volume":"9","author":"Schwaber","year":"2003","journal-title":"Emerging Infectious Diseases"},{"issue":"6","key":"10.1016\/bs.ampbs.2024.04.006_bib161","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1139\/w2012-043","article-title":"Chromatin immunoprecipitation identifies genes under direct VraSR regulation in Staphylococcus aureus","volume":"58","author":"Sengupta","year":"2012","journal-title":"Canadian Journal of Microbiology"},{"issue":"12","key":"10.1016\/bs.ampbs.2024.04.006_bib162","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1128\/AAC.48.12.4566-4573.2004","article-title":"Penicillin-binding protein 2 is essential for expression of high-level vancomycin resistance and cell wall synthesis in vancomycin- resistant Staphylococcus aureus carrying the enterococcal vanA gene complex","volume":"48","author":"Severin","year":"2004","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"6193","key":"10.1016\/bs.ampbs.2024.04.006_bib163","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1126\/science.1254522","article-title":"MurJ is the flippase of lipid-linked precursors for peptidoglycan biogenesis","volume":"345","author":"Sham","year":"2014","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.ampbs.2024.04.006_bib164","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69058-z","article-title":"Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: A systematic review and meta-analysis","volume":"10","author":"Shariati","year":"2020","journal-title":"Scientific Reports"},{"issue":"8","key":"10.1016\/bs.ampbs.2024.04.006_bib165","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1128\/AAC.01563-10","article-title":"walK and clpP mutations confer reduced vancomycin susceptibility in Staphylococcus aureus","volume":"55","author":"Shoji","year":"2011","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"27","key":"10.1016\/bs.ampbs.2024.04.006_bib166","doi-asserted-by":"crossref","first-page":"18942","DOI":"10.1074\/jbc.274.27.18942","article-title":"Inactivated pbp4 in highly glycopeptide-resistant laboratory mutants of Staphylococcus aureus","volume":"274","author":"Sieradzki","year":"1999","journal-title":"Journal of Biological Chemistry"},{"issue":"8","key":"10.1016\/bs.ampbs.2024.04.006_bib167","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1128\/jb.179.8.2557-2566.1997","article-title":"Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus","volume":"179","author":"Sieradzki","year":"1997","journal-title":"Journal of Bacteriology"},{"issue":"24","key":"10.1016\/bs.ampbs.2024.04.006_bib168","doi-asserted-by":"crossref","first-page":"7103","DOI":"10.1128\/JB.185.24.7103-7110.2003","article-title":"Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of Staphylococcus aureus","volume":"185","author":"Sieradzki","year":"2003","journal-title":"Journal of Bacteriology"},{"issue":"20","key":"10.1016\/bs.ampbs.2024.04.006_bib169","doi-asserted-by":"crossref","first-page":"7316","DOI":"10.1128\/JB.00734-07","article-title":"Characterization of IsaA and SceD, two putative lytic transglycosylases of Staphylococcus aureus","volume":"189","author":"Stapleton","year":"2007","journal-title":"Journal of Bacteriology"},{"issue":"4","key":"10.1016\/bs.ampbs.2024.04.006_bib170","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijantimicag.2011.09.030","article-title":"Meticillin-resistant Staphylococcus aureus (MRSA): Global epidemiology and harmonisation of typing methods","volume":"39","author":"Stefani","year":"2012","journal-title":"International Journal of Antimicrobial Agents"},{"key":"10.1016\/bs.ampbs.2024.04.006_bib171","doi-asserted-by":"crossref","first-page":"e11764","DOI":"10.7717\/peerj.11764","article-title":"Effect of genetic background on the evolution of Vancomycin-Intermediate Staphylococcus aureus (VISA)","volume":"9","author":"Su","year":"2021","journal-title":"PeerJ"},{"issue":"24","key":"10.1016\/bs.ampbs.2024.04.006_bib172","doi-asserted-by":"crossref","first-page":"6253","DOI":"10.1016\/j.bmc.2016.05.052","article-title":"The action mechanism of daptomycin","volume":"24","author":"Taylor","year":"2016","journal-title":"Bioorganic & Medicinal Chemistry"},{"issue":"9","key":"10.1016\/bs.ampbs.2024.04.006_bib173","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1086\/513203","article-title":"The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus","volume":"44","author":"Tenover","year":"2007","journal-title":"Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America"},{"issue":"1","key":"10.1016\/bs.ampbs.2024.04.006_bib174","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-73108-x","article-title":"Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA)","volume":"10","author":"Thitiananpakorn","year":"2020","journal-title":"Scientific Reports"},{"issue":"22","key":"10.1016\/bs.ampbs.2024.04.006_bib175","doi-asserted-by":"crossref","first-page":"6764","DOI":"10.3390\/molecules26226764","article-title":"Understanding the mechanism of action of NAI-112, a lanthipeptide with potent antinociceptive activity","volume":"26","author":"Tocchetti","year":"2021","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"10","key":"10.1016\/bs.ampbs.2024.04.006_bib176","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1099\/mic.0.26426-0","article-title":"Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon","volume":"149","author":"Utaida","year":"2003","journal-title":"Microbiology (Reading, England)"},{"issue":"4","key":"10.1016\/bs.ampbs.2024.04.006_bib177","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1128\/AAC.50.4.1541-1545.2006","article-title":"Autolytic properties of glycopeptide-intermediate Staphylococcus aureus Mu50","volume":"50","author":"Utaida","year":"2006","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"18","key":"10.1016\/bs.ampbs.2024.04.006_bib178","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1007\/s40265-015-0505-8","article-title":"Lipoglycopeptide antibacterial agents in Gram-positive infections: A comparative review","volume":"75","author":"Van Bambeke","year":"2015","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/bs.ampbs.2024.04.006_bib179","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/cid\/cir935","article-title":"The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: A systematic review and meta-analysis","volume":"54","author":"van Hal","year":"2012","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1016\/bs.ampbs.2024.04.006_bib180","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1128\/AAC.01133-10","article-title":"Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates","volume":"55","author":"van Hal","year":"2011","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"5","key":"10.1016\/bs.ampbs.2024.04.006_bib181","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10096-010-1128-3","article-title":"Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-na\u00efve patient\u2014A review of the literature","volume":"30","author":"van Hal","year":"2011","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"issue":"2","key":"10.1016\/bs.ampbs.2024.04.006_bib803","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/jac\/dkt354","article-title":"In vivo evolution of antimicrobial resistance in a series of Staphylococcus aureus patient isolates: The entire picture or a cautionary tale?","volume":"69","author":"Van Hal","year":"2014","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"1","key":"10.1016\/bs.ampbs.2024.04.006_bib182","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/infdis\/jit127","article-title":"Alternative mutational pathways to intermediate resistance to vancomycin in methicillin-resistant Staphylococcus aureus","volume":"208","author":"Vidaillac","year":"2013","journal-title":"The Journal of Infectious Diseases"},{"issue":"1","key":"10.1016\/bs.ampbs.2024.04.006_bib183","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM200101043440102","article-title":"Nasal carriage as a source of Staphylococcus aureus bacteremia","volume":"344","author":"Von Eiff","year":"2001","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1016\/bs.ampbs.2024.04.006_bib184","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ijantimicag.2013.07.010","article-title":"High vancomycin minimum inhibitory concentrations with heteroresistant vancomycin-intermediate Staphylococcus aureus in methicillin-resistant S. aureus bacteraemia patients","volume":"42","author":"Wang","year":"2013","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"11","key":"10.1016\/bs.ampbs.2024.04.006_bib805","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1128\/JCM.00539-09","article-title":"Molecular and phenotypic characteristics of methicillin-resistant and vancomycin-intermediate Staphylococcus aureus isolates from patients with septic arthritis","volume":"47","author":"Wang","year":"2009","journal-title":"Journal of Clinical Microbiology"},{"issue":"7","key":"10.1016\/bs.ampbs.2024.04.006_bib185","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1128\/JCM.02144-10","article-title":"Impact of rpoB mutations on reduced vancomycin susceptibility in Staphylococcus aureus","volume":"49","author":"Watanabe","year":"2011","journal-title":"Journal of Clinical Microbiology"},{"issue":"5770","key":"10.1016\/bs.ampbs.2024.04.006_bib186","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1126\/science.1123539","article-title":"Darwinian evolution can follow only very few mutational paths to fitter proteins","volume":"312","author":"Weinreich","year":"2006","journal-title":"Science (New York, N. Y.)"},{"issue":"1","key":"10.1016\/bs.ampbs.2024.04.006_bib187","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1086\/317542","article-title":"Vancomycin-intermediate and -resistant Staphylococcus aureus: What the infectious disease specialist needs to know","volume":"32","author":"Weinstein","year":"2001","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1016\/bs.ampbs.2024.04.006_bib188","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0195-6701(95)90079-9","article-title":"The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection","volume":"31","author":"Wenzel","year":"1995","journal-title":"The Journal of Hospital Infection"},{"issue":"6","key":"10.1016\/bs.ampbs.2024.04.006_bib189","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2020.08.025","article-title":"Dalbavancin exposure in vitro selects for dalbavancin-non-susceptible and vancomycin-intermediate strains of methicillin-resistant Staphylococcus aureus","volume":"27","author":"Werth","year":"2021","journal-title":"Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"issue":"4","key":"10.1016\/bs.ampbs.2024.04.006_bib190","doi-asserted-by":"crossref","first-page":"429.e1","DOI":"10.1016\/j.cmi.2017.07.028","article-title":"Emergence of dalbavancin non-susceptible, vancomycin-intermediate Staphylococcus aureus (VISA) after treatment of MRSA central line-associated bloodstream infection with a dalbavancin- and vancomycin-containing regimen","volume":"24","author":"Werth","year":"2018","journal-title":"Clinical Microbiology and Infection"},{"issue":"9435","key":"10.1016\/bs.ampbs.2024.04.006_bib191","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0140-6736(04)16897-9","article-title":"Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers","volume":"364","author":"Wertheim","year":"2004","journal-title":"Lancet (London, England)"},{"issue":"12","key":"10.1016\/bs.ampbs.2024.04.006_bib192","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1473-3099(05)70295-4","article-title":"The role of nasal carriage in Staphylococcus aureus infections","volume":"5","author":"Wertheim","year":"2005","journal-title":"The Lancet Infectious Diseases"},{"issue":"2","key":"10.1016\/bs.ampbs.2024.04.006_bib193","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijantimicag.2012.04.003","article-title":"High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia","volume":"40","author":"Wi","year":"2012","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"1","key":"10.1016\/bs.ampbs.2024.04.006_bib194","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1128\/br.27.1.56-71.1963","article-title":"Healthy carriage of Staphylococcus aureus: Its prevalence and importance","volume":"27","author":"Williams","year":"1963","journal-title":"Bacteriological Reviews"},{"issue":"12","key":"10.1016\/bs.ampbs.2024.04.006_bib195","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1086\/668433","article-title":"Impact of vancomycin minimum inhibitory concentration on mortality among critically Ill patients with methicillin-resistant Staphylococcus aureus bacteremia","volume":"33","author":"Woods","year":"2012","journal-title":"Infection Control & Hospital Epidemiology"},{"issue":"4","key":"10.1016\/bs.ampbs.2024.04.006_bib196","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/jac\/47.4.399","article-title":"A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital","volume":"47","author":"Wootton","year":"2001","journal-title":"The Journal of Antimicrobial Chemotherapy"},{"issue":"15","key":"10.1016\/bs.ampbs.2024.04.006_bib197","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1128\/JB.01412-10","article-title":"Wall teichoic acid-dependent adsorption of staphylococcal siphovirus and myovirus","volume":"193","author":"Xia","year":"2011","journal-title":"Journal of Bacteriology"},{"issue":"2\u20133","key":"10.1016\/bs.ampbs.2024.04.006_bib198","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijmm.2009.10.001","article-title":"The wall teichoic acid and lipoteichoic acid polymers of Staphylococcus aureus","volume":"300","author":"Xia","year":"2010","journal-title":"International Journal of Medical Microbiology: IJMM"},{"issue":"6","key":"10.1016\/bs.ampbs.2024.04.006_bib703","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1128\/AAC.05159-14","article-title":"Evolution and single-nucleotide polymorphisms in methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to vancomycin and daptomycin, based on determination of the complete genome","volume":"59","author":"Yamaguchi","year":"2015","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"9","key":"10.1016\/bs.ampbs.2024.04.006_bib199","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113154","article-title":"Cross-species communication via agr controls phage susceptibility in Staphylococcus aureus","volume":"42","author":"Yang","year":"2023","journal-title":"Cell Reports"},{"issue":"12","key":"10.1016\/bs.ampbs.2024.04.006_bib200","doi-asserted-by":"crossref","first-page":"a026989","DOI":"10.1101\/cshperspect.a026989","article-title":"Approved glycopeptide antibacterial drugs: Mechanism of action and resistance","volume":"6","author":"Zeng","year":"2016","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"5","key":"10.1016\/bs.ampbs.2024.04.006_bib201","first-page":"664","article-title":"Predicting folding free energy changes upon single point mutations","volume":"28","author":"Zhang","year":"2012","journal-title":"Bioinformatics (Oxford, England)"},{"key":"10.1016\/bs.ampbs.2024.04.006_bib202","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/1471-2180-12-240","article-title":"Molecular characterization of rifampicin-resistant Staphylococcus aureus isolates in a Chinese teaching hospital from Anhui, China","volume":"12","author":"Zhou","year":"2012","journal-title":"BMC Microbiology"},{"issue":"2","key":"10.1016\/bs.ampbs.2024.04.006_bib203","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmm.2021.151473","article-title":"A novel mutation of walK confers vancomycin-intermediate resistance in methicillin-susceptible Staphylococcus aureus","volume":"311","author":"Zhu","year":"2021","journal-title":"International Journal of Medical Microbiology"},{"issue":"10","key":"10.1016\/bs.ampbs.2024.04.006_bib204","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1128\/AAC.00185-10","article-title":"Dissemination of an enterococcus Inc18-Like vanA plasmid associated with vancomycin-resistant Staphylococcus aureus","volume":"54","author":"Zhu","year":"2010","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"7","key":"10.1016\/bs.ampbs.2024.04.006_bib905","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1128\/AAC.49.7.2687-2692.2005","article-title":"Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (AGR) function","volume":"49","author":"Sakoulas","year":"2005","journal-title":"Antimicrobial Agents and Chemotherapy"}],"container-title":["Advances in Microbial Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065291124000109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065291124000109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T20:06:30Z","timestamp":1730750790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065291124000109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9780443295423"],"references-count":222,"URL":"https:\/\/doi.org\/10.1016\/bs.ampbs.2024.04.006","relation":{},"ISSN":["0065-2911"],"issn-type":[{"value":"0065-2911","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}